The Operator Who Became the Investor
Napa, California is an unusual home base for a venture capital investor betting on the future of food. But Roger Salameh has never taken the obvious route. He started his career at Calgene in 1992 - the Davis, California biotech company that created the Flavr Savr tomato, the world's first commercially sold genetically engineered food. That alone tells you something about his entry point into this industry: not at the edge, but right at the moment of ignition.
From Calgene he moved to Monsanto, where he served as Director of Business Development during the late 1990s - a period when agricultural genetics was being remade from the ground up and every strategic deal carried an outsized weight. Then came Arcadia Biosciences, the agri-biotech company working on yield-boosting and efficiency-improving traits for major crops. Salameh joined in 2003 as VP of Business Development and stayed for over a decade, eventually stepping into the interim CEO seat in February 2016 before transitioning to Chief Operating Officer three months later when a permanent CEO was named.
He stepped into the CEO seat at a publicly traded agri-biotech company for three months - not as a career move, but because the company needed someone who understood both the science and the street.
Arcadia Biosciences - February to May 2016That COO-then-back-to-advisor arc is what separates Salameh from the career VC. He didn't climb through investment banking or management consulting into venture. He ran things. He signed the partnerships. He sat in the board meetings on the operating side. When he finally made the move to back founders rather than be one, he brought something most fund managers spend years pretending they have: actual operating depth in the exact sector he's investing in.
Madrid + Napa: Swanlaab's Transatlantic Bridge
In January 2022, Salameh joined Swanlaab Venture Factory as General Partner of its AgriFood Fund I. Swanlaab is a Madrid-based venture factory - not a traditional VC fund, but a company-building platform that invests from concept validation through early Series A, often with deeper operational involvement than a standard check-writer offers. The firm had already built a reputation across deep tech and B2B software in Spain; the AgriFood Fund was its move into the food and agriculture technology space.
What Swanlaab AgriFood Fund I Backs
Early-stage agri-food tech startups across the value chain - from concept validation and late-seed through early Series A. The fund targets companies solving real problems in food production, supply chains, sustainability, and agricultural technology, with a particular focus on science-forward ventures that need both capital and operational guidance.
Salameh bridges two worlds simultaneously. He's based in Napa - wine country, surrounded by the agricultural industry he has spent his career studying - while operating as a General Partner for a European venture factory with offices on Calle de Velazquez in Madrid. In an era when "global investor" often means "flies to two conferences a year," Salameh is genuinely transatlantic in his deal flow and networks.
Swanlaab's broader portfolio has grown to 63+ companies. The agri-food segment Salameh oversees sits alongside the firm's deep tech and software investments, giving the fund a diversified but focused profile. Notable portfolio companies in the broader Swanlaab ecosystem include MOA Foodtech (precision fermentation for sustainable ingredients), Leemons (open-source collaborative learning), and Landbot (conversational AI for customer engagement).
Where Swanlaab's AgriFood Thesis Points
B2B precision fermentation platform developing sustainable food ingredients.
Agri-FoodOpen Source and SaaS collaborative learning platform for education.
EdTechConversational customer engagement platform powering no-code chatbot experiences.
B2B SaaSLogistics and shipping innovation in the Swanlaab portfolio ecosystem.
LogisticsEarly-stage agri-tech venture backed through Swanlaab's company-building model.
AgriTechSwanlaab's full portfolio spans deep tech, agri-food, B2B software and more.
Full PortfolioDnA Advisory Services: The Other Business
Parallel to his Swanlaab role, Salameh runs DnA Advisory Services - a U.S.-based consultancy he founded to help AgTech and FoodTech companies navigate the complex path from innovation to commercialization. The firm operates across the U.S. and Europe, bringing together a team with a combined 60+ years of experience in strategy, commercial development, technology transfer, and investor diligence.
The advisory work isn't incidental. It's where Salameh's pattern recognition stays sharp. He sees the deal flow from two angles: as a fund manager evaluating where to deploy capital, and as an advisor sitting inside companies trying to commercialize. The feedback loop between those two roles is the kind of market intelligence that money alone can't buy.
From agribusiness product manager in 1992 to multi-continent venture capitalist in 2022 - it took thirty years and three industry giants, but Salameh got there carrying real operating weight, not just a pitch deck.
Three Decades, One Consistent Bet
Calgene - Product Manager. Joins one of the most talked-about agri-biotech companies of the decade - the team behind the Flavr Savr tomato, the first genetically engineered food approved for sale. An unconventional entry point into the industry's most experimental edge.
Monsanto - Director of Business Development. Moves to the industry's largest player during a pivotal era of agricultural genetics. Leads strategic partnerships and business development at a company in the process of redefining global crop science.
Arcadia Biosciences - VP of Business Development. Joins the agri-biotech startup focused on yield improvement and crop efficiency traits. Builds and leads the business development function for over a decade, structuring key industry collaborations.
Arcadia Biosciences - Interim CEO, then COO. Steps into the top seat in February 2016 as the publicly traded company searches for permanent leadership. Transitions to Chief Operating Officer in May 2016, continuing to drive operational execution through early 2017.
Founded DnA Advisory Services. Launches a consultancy dedicated to helping AgTech and FoodTech companies move from innovation to commercial scale. Brings together a transatlantic team with 60+ combined years of industry experience.
Swanlaab Venture Factory - General Partner, AgriFood Fund I. Joins the Madrid-based venture factory as General Partner of its first dedicated agri-food tech fund. Brings a rare combination of sector expertise, operating experience, and investment acumen to back early-stage founders.
New York University
Salameh earned a Bachelor of Arts in Economics and Political Science from New York University. The dual focus - market systems and political power - is a reasonable foundation for someone who spent decades navigating the intersection of agricultural science, corporate strategy, and regulatory environments.
The Rare Combination
Most venture investors in agri-food tech arrive from one of three directions: finance, consulting, or a single founding experience. Salameh's profile is different. He has spent time at every phase of the company lifecycle - product management at an early-stage startup (Calgene), business development at a multinational (Monsanto), VP-to-COO at a growth-stage public company (Arcadia), founder of an advisory firm (DnA), and now fund manager at a venture factory (Swanlaab).
That breadth isn't just a resume talking point. It means he has sat across the table from investors, run the pitches, structured the partnerships, and managed the quarterly earnings calls. When a founder in his portfolio hits a wall with a strategic partnership or a licensing negotiation, Salameh has been in that exact room.
The agri-food tech sector rewards pattern recognition above almost everything else - and Salameh has been collecting patterns since the 1990s, when the industry was still working out its first principles.
Swanlaab AgriFood Fund I - investing from concept to Series AHe is also, by nature of his biography, deeply transatlantic. Living in Napa while deploying capital through a Madrid venture factory means he moves between two distinct innovation ecosystems - the U.S. agri-biotech establishment and the European deep-tech startup scene - with a fluency that most investors in either geography lack.